Prostate cancer decisions — 2024

The Veteran's prostate cancer was not shown during active service or for many years thereafter, and the Board found no evidence of herbicide agent exposure. Therefore, service connection for prostate cancer is denied.

The Board denied service connection for various conditions, including psychiatric disorders, bilateral leg swelling, diabetes mellitus, right knee and ankle pain, left hip pain, chronic back pain, hypertension, headaches, and prostate cancer. The evidence did not support a finding that these conditions were related to service or the presumption of herbicide exposure.

The Board has granted service connection for prostate cancer and diabetes mellitus, Type II, as these conditions are presumed to be due to the Veteran's in-service exposure to herbicide agents.

The Board has decided to remand the case due to a duty to assist error regarding secondary service connection and Agent Orange exposure. The Veteran's erectile dysfunction is being reviewed again with additional medical opinions.

The Veteran's service connection claim for prostate cancer and erectile dysfunction due to prostate cancer is granted, with the presumption of exposure to herbicide agents (Agent Orange) in service.

The Board has granted service connection for tinnitus. The remaining claims are remanded due to the need for additional examinations and opinions.

The Board has determined that the Veteran did not have a pending claim for accrued benefits at the time of his death. The appeal regarding service connection for cause of death is remanded due to insufficient evidence on the etiology of the prostate cancer.

The Veteran's claims for service connection and compensation under 38 U.S.C. § 1151 are being remanded due to the need for additional medical opinions regarding the nature and etiology of his disabilities, specifically addressing VA's inaction prior to January 2017.

The Veteran's diabetes mellitus, prostate cancer and arteriosclerotic heart disease are granted on a presumptive basis due to exposure to herbicide agents during service in the territorial waters of Guam. The effective date is August 10, 2022.

The Veteran's prostate cancer residuals resulted in daytime voiding intervals between one and two hours and nighttime awakening to void three or four times. The Board found that the evidence did not support a higher rating based on urinary frequency, as his daytime voiding interval was reported to be between 1 and 2 hours, and he awakened to void three to four times at night.

The Veteran's prostate cancer residuals, specifically bowel dysfunction, were evaluated at a 30 percent rating from August 1, 2013, to December 22, 2022. The Board denied an increased evaluation for this condition.

The Board has remanded the case due to insufficient compliance with previous instructions regarding Air Force flight logs and manifests. The Veteran's claim for service connection for prostate cancer is based on alleged exposure to herbicide agents during his CIA activities.

Service connection for tinnitus, prostate cancer, and hypertension is granted. The Veteran's hypertension is granted on a presumptive basis due to exposure to herbicides in service. Service connection for other conditions is remanded.

The Veteran's claim for a higher rating for diabetes mellitus was denied, and the TDIU claim prior to May 13, 2019, was granted.

The Veteran's claims for service connection for diabetes mellitus, prostate cancer, a back condition, left knee osteoarthritis, and right knee osteoarthritis have all been denied. The Veteran's bilateral hearing loss has been granted a 70% rating from August 31, 2018 to February 10, 2020.

The Board has remanded the case due to incomplete development and the need for a new VA examination. The Veteran's prostate cancer is being reviewed in light of his service on the USS Barney, exposure at the Balboa Naval Medical Center, and his claims of asbestos exposure.

Your claim for service connection for prostate cancer has been granted, but the appeal is dismissed because a new rating decision from VA granted it in May 2023.

The Board has remanded the case due to insufficient evidence regarding the Veteran's claimed exposure to herbicide agents and his service connection for prostate cancer. A new VA opinion is needed to determine if his prostate cancer is related to firefighting foam exposure during military service.

The Veteran's service-connected disabilities did not prevent him from securing or following a substantially gainful occupation prior to October 11, 2021.

The Veteran's claim for a higher rating of prostate cancer is granted. The Board finds that the criteria for a 100 percent rating evaluation for prostate cancer are met and the Appellant's claim for an increased rating must be granted. However, the issue of service connection for erectile dysfunction remains remanded due to a duty to assist error.